<code id='69D601B626'></code><style id='69D601B626'></style>
    • <acronym id='69D601B626'></acronym>
      <center id='69D601B626'><center id='69D601B626'><tfoot id='69D601B626'></tfoot></center><abbr id='69D601B626'><dir id='69D601B626'><tfoot id='69D601B626'></tfoot><noframes id='69D601B626'>

    • <optgroup id='69D601B626'><strike id='69D601B626'><sup id='69D601B626'></sup></strike><code id='69D601B626'></code></optgroup>
        1. <b id='69D601B626'><label id='69D601B626'><select id='69D601B626'><dt id='69D601B626'><span id='69D601B626'></span></dt></select></label></b><u id='69D601B626'></u>
          <i id='69D601B626'><strike id='69D601B626'><tt id='69D601B626'><pre id='69D601B626'></pre></tt></strike></i>

          focus

          focus

          author:Wikipedia    Page View:62
          John-Arne-Røttingen, a white man with short hair, smiles at the camera wearing blue suits — biotech coverage from STAT
          John-Arne Røttingen is the head of the Wellcome Trust, one of the world’s top private funders of biomedical research. Illustration: STAT; Source: Wellcome Trust

          LONDON — The key groups involved in addressing global health problems often include governments, foundations, and pharmaceutical companies.

          But to John-Arne Røttingen, the new head of the Wellcome Trust, one of the world’s top private funders of biomedical research, there’s another sector that should be getting involved — the tech industry.

          advertisement

          The Alphabets and Amazons of the world have been growing their health-related initiatives, but the industry is rarely mentioned when neglected public health issues are discussed, Røttingen argued.

          STAT+ Exclusive Story

          Already have an account? Log in

          STAT+

          This article is exclusive to STAT+ subscribers

          Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

          Already have an account? Log in

          Already have an account? Log in

          Monthly

          $39

          Totals $468 per year

          $39/month Get Started

          Totals $468 per year

          Starter

          $30

          for 3 months, then $39/month

          $30 for 3 months Get Started

          Then $39/month

          Annual

          $399

          Save 15%

          $399/year Get Started

          Save 15%

          11+ Users

          Custom

          Savings start at 25%!

          Request A Quote Request A Quote

          Savings start at 25%!

          2-10 Users

          $300

          Annually per user

          $300/year Get Started

          $300 Annually per user

          View All Plans

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          The Supreme Court will review a ruling striking down a domestic violence federal gun ban
          The Supreme Court will review a ruling striking down a domestic violence federal gun ban

          WASHINGTON--TheSupremeCourtwillreviewarulingstrikingdownadomesticviolencefederalgunban.

          read more
          The tragedy of Johnson & Johnson’s Covid vaccine
          The tragedy of Johnson & Johnson’s Covid vaccine

          ANorthwellHealthregisterednursefillsasyringewiththeJohnson&JohnsonCovid-19vaccineatapop-upvaccin

          read more
          Dobbs anniversary: the lost opportunity of abortion as health care
          Dobbs anniversary: the lost opportunity of abortion as health care

          NathanHoward/GettyImagesReflectingonthisfirstanniversaryoftheSupremeCourt’sdecisioninDobbstooverturn

          read more

          Readout LOUD podcast: Biotech layoffs, stock slump, 2024 preview

          Whyarerichbiotechscuttingcosts?HasJPMWeekalreadywornoff?Andwhat’sgoingtomovemarketsin2024?Wecoverall